Cite
HARVARD Citation
Mukherjee, A. et al. (2022). Exposure‐Response Characterization of Tofacitinib Efficacy in Moderate to Severe Ulcerative Colitis: Results From Phase II and Phase III Induction and Maintenance Studies. Clinical pharmacology & therapeutics. 112 (1), pp. 90-100. [Online].